Biomarkers Commercialization: Diagnostics & Drug Development

  • Evaluating the role of commercial diagnostic strategy in supporting launch of companion diagnostics
  • Developing optimal strategies for test implementation and adoption at launch
  • Assessing the direct impact of suboptimal tests on patient outcomes